HealthDay - MONDAY, Oct. 13 (HealthDay News) -- Quick tumor removal and immunotherapy can reverse the progress of a newly recognized neurological disease called anti-NMDA-receptor encephalitis (ANRE), a new study says.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.